ATH-1105, a small-molecule positive modulator of the neurotrophic HGF system, is neuroprotective, preserves neuromotor function, and extends survival in preclinical models of ALS

Overview of attention for article published in Frontiers in Neuroscience, February 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 12 news stories from 12 outlets.

ATH-1105 protected various cell culture systems from glutamate-mediated toxicity and its pathological alterations, which…

Results demonstrate ATH-1105 is neuroprotective, preserves motor and nerve function and extends survival in preclinical models…

BOTHELL, WA, Feb. 8, 2024 — Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on…

BOTHELL, WA, Feb. 8, 2024 — Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 8 additional news stories.